Form 8-K - Current report:
SEC Accession No. 0001193125-24-215939
Filing Date
2024-09-09
Accepted
2024-09-09 16:33:00
Documents
13
Period of Report
2024-09-09
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d881331d8k.htm   iXBRL 8-K 61655
  Complete submission text file 0001193125-24-215939.txt   187435

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ions-20240909.xsd EX-101.SCH 2507
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20240909_lab.xml EX-101.LAB 17202
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20240909_pre.xml EX-101.PRE 10786
15 EXTRACTED XBRL INSTANCE DOCUMENT d881331d8k_htm.xml XML 3718
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 241287647
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)